HuGE Literature Finder
Records 1-32
|
Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.
Cancer science 2019 Dec . Jiang Lingxu, Luo Yingwan, Zhu Shuanghong, Wang Lu, Ma Liya, Zhang Hua, Shen Chuying, Yang Wenli, Ren Yanling, Zhou Xinping, Mei Chen, Ye Li, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
|
Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis.
Blood advances 2019 Nov 3 (22): 3579-3589. McGraw Kathy L, Cheng Chia-Ho, Chen Y Ann, Hou Hsin-An, Nilsson Björn, Genovese Giulio, Cluzeau Thomas, Pellagatti Andrea, Przychodzen Bartlomiej P, Mallo Mar, Arenillas Leonor, Mohamedali Azim, Adès Lionel, Sallman David A, Padron Eric, Sokol Lubomir, Moreilhon Chimene, Raynaud Sophie, Tien Hwei-Fang, Boultwood Jacqueline, Ebert Benjamin L, Sole Francesc, Fenaux Pierre, Mufti Ghulam J, Maciejewski Jaroslaw P, Kanetsky Peter A, List Alan |
|
Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern.
Blood advances 2019 Oct 3 (20): 3111-3122. Berger Gerbrig, Gerritsen Mylene, Yi Guoqiang, Koorenhof-Scheele Theresia N, Kroeze Leonie I, Stevens-Kroef Marian, Yoshida Kenichi, Shiraishi Yuichi, van den Berg Eva, Schepers Hein, Huls Geert, Mulder André B, Ogawa Seishi, Martens Joost H A, Jansen Joop H, Vellenga E |
|
[Mutation analysis of 77 patients with normal-karyotype myelodysplastic syndrome].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 Sep 36 (9): 857-861. Qin Wei, Chen Meiyu, Cai Xiaohui, Chao Hongying, Liu Jie, Jiang Naike, Zhou Min, Lu Xuzhang, Chen Suning, Zhang Ri, He Chuan, Wang Qi |
|
Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
Genes, chromosomes & cancer 2019 Apr . Hartmann Luise, Haferlach Claudia, Meggendorfer Manja, Kern Wolfgang, Haferlach Torsten, Stengel An |
|
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes.
Leukemia 2019 Feb . Follo Matilde Y, Pellagatti Andrea, Armstrong Richard N, Ratti Stefano, Mongiorgi Sara, De Fanti Sara, Bochicchio Maria Teresa, Russo Domenico, Gobbi Marco, Miglino Maurizio, Parisi Sarah, Martinelli Giovanni, Cavo Michele, Luiselli Donata, McCubrey James A, Suh Pann-Ghill, Manzoli Lucia, Boultwood Jacqueline, Finelli Carlo, Cocco Luc |
|
Mutations and prognosis in myelodysplastic syndromes: Karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model.
American journal of hematology 2018 Feb . Gangat Naseema, Mudireddy Mythri, Lasho Terra L, Finke Christy M, Nicolosi Maura, Szuber Natasha, Patnaik Mrinal M, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
|
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.
American journal of hematology 2017 Sep . Tefferi Ayalew, Lasho Terra L, Patnaik Mrinal M, Saeed Lyla, Mudireddy Mythri, Idossa Dame, Finke Christy, Ketterling Rhett P, Pardanani Animesh, Gangat Nasee |
|
Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.
American journal of hematology 2017 Mar . Patnaik Mrinal M, Barraco Daniela, Lasho Terra L, Finke Christy M, Reichard Kaaren, Hoversten Katherine P, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
|
Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia.
British journal of haematology 2017 09 178 (5): 764-771. Alvarez-Larrán Alberto, Senín Alicia, Fernández-Rodríguez Concepción, Pereira Arturo, Arellano-Rodrigo Eduardo, Gómez Montse, Ferrer-Marin Francisca, Martínez-López Joaquín, Camacho Laura, Colomer Dolors, Angona Anna, Navarro Blanca, Cervantes Francisco, Besses Carlos, Bellosillo Beatriz, Hernández-Boluda Juan Carl |
|
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Sep . Della Porta Matteo G, Gallì Anna, Bacigalupo Andrea, Zibellini Silvia, Bernardi Massimo, Rizzo Ettore, Allione Bernardino, van Lint Maria Teresa, Pioltelli Pietro, Marenco Paola, Bosi Alberto, Voso Maria Teresa, Sica Simona, Cuzzola Mariella, Angelucci Emanuele, Rossi Marianna, Ubezio Marta, Malovini Alberto, Limongelli Ivan, Ferretti Virginia V, Spinelli Orietta, Tresoldi Cristina, Pozzi Sarah, Luchetti Silvia, Pezzetti Laura, Catricalà Silvia, Milanesi Chiara, Riva Alberto, Bruno Benedetto, Ciceri Fabio, Bonifazi Francesca, Bellazzi Riccardo, Papaemmanuil Elli, Santoro Armando, Alessandrino Emilio P, Rambaldi Alessandro, Cazzola Mar |
|
Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutations.
Oncotarget 2016 Jun . Shin Sang-Yong, Lee Seung-Tae, Kim Hee-Jin, Cho Eun Hae, Kim Jong-Won, Park Silvia, Jung Chul Won, Kim Sun-H |
|
Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.
PloS one 2016 11 (10): e0164370. Abáigar María, Robledo Cristina, Benito Rocío, Ramos Fernando, Díez-Campelo María, Hermosín Lourdes, Sánchez-Del-Real Javier, Alonso Jose M, Cuello Rebeca, Megido Marta, Rodríguez Juan N, Martín-Núñez Guillermo, Aguilar Carlos, Vargas Manuel, Martín Ana A, García Juan L, Kohlmann Alexander, Del Cañizo M Consuelo, Hernández-Rivas Jesús |
|
Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Aug 21 (15): 3541-51. Tsai Shu-Chun, Shih Lee-Yung, Liang Sung-Tzu, Huang Ying-Jung, Kuo Ming-Chung, Huang Chein-Fuang, Shih Yu-Shu, Lin Tung-Huei, Chiu Ming-Chun, Liang Der-Cher |
|
Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity.
Haematologica 2015 Jan 100 (1): 42-8. Zhang Michael Y, Keel Siobán B, Walsh Tom, Lee Ming K, Gulsuner Suleyman, Watts Amanda C, Pritchard Colin C, Salipante Stephen J, Jeng Michael R, Hofmann Inga, Williams David A, Fleming Mark D, Abkowitz Janis L, King Mary-Claire, Shimamura Aki |
|
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Sep 32 (25): 2691-8. Bejar Rafael, Stevenson Kristen E, Caughey Bennett, Lindsley R Coleman, Mar Brenton G, Stojanov Petar, Getz Gad, Steensma David P, Ritz Jerome, Soiffer Robert, Antin Joseph H, Alyea Edwin, Armand Philippe, Ho Vincent, Koreth John, Neuberg Donna, Cutler Corey S, Ebert Benjamin |
|
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.
American journal of hematology 2014 Aug 89 (8): E109-15. Lin Chien-Chin, Hou Hsin-An, Chou Wen-Chien, Kuo Yuan-Yeh, Wu Shang-Ju, Liu Chieh-Yu, Chen Chien-Yuan, Tseng Mei-Hsuan, Huang Chi-Fei, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Hsu Szu-Chun, Ko Bor-Sheng, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
|
Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.
Blood 2014 Apr 123 (14): 2229-37. Skokowa Julia, Steinemann Doris, Katsman-Kuipers Jenny E, Zeidler Cornelia, Klimenkova Olga, Klimiankou Maksim, Unalan Murat, Kandabarau Siarhei, Makaryan Vahagn, Beekman Renee, Behrens Kira, Stocking Carol, Obenauer Julia, Schnittger Susanne, Kohlmann Alexander, Valkhof Marijke G, Hoogenboezem Remco, Göhring Gudrun, Reinhardt Dirk, Schlegelberger Brigitte, Stanulla Martin, Vandenberghe Peter, Donadieu Jean, Zwaan C Michel, Touw Ivo P, van den Heuvel-Eibrink Marry M, Dale David C, Welte Ka |
|
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.
Leukemia 2014 Feb 28 (2): 241-7. Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, Yoshida K, Roller A, Nadarajah N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler H P, Klein H-U, Dugas M, Aburatani H, Kohlmann A, Miyano S, Haferlach C, Kern W, Ogawa |
|
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
Blood 2013 Oct 122 (18): 3169-77. Damm Frederik, Chesnais Virginie, Nagata Yasunobu, Yoshida Kenichi, Scourzic Laurianne, Okuno Yusuke, Itzykson Raphael, Sanada Masashi, Shiraishi Yuichi, Gelsi-Boyer Véronique, Renneville Aline, Miyano Satoru, Mori Hiraku, Shih Lee-Yung, Park Sophie, Dreyfus François, Guerci-Bresler Agnes, Solary Eric, Rose Christian, Cheze Stéphane, Prébet Thomas, Vey Norbert, Legentil Marion, Duffourd Yannis, de Botton Stéphane, Preudhomme Claude, Birnbaum Daniel, Bernard Olivier A, Ogawa Seishi, Fontenay Michaela, Kosmider Olivi |
|
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.
Leukemia 2013 Jan 27 (1): 82-91. Schnittger S, Eder C, Jeromin S, Alpermann T, Fasan A, Grossmann V, Kohlmann A, Illig T, Klopp N, Wichmann H-E, Kreuzer K-A, Schmid C, Staib P, Peceny R, Schmitz N, Kern W, Haferlach C, Haferlach |
|
RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.
Haematologica 2012 Dec 97 (12): 1909-15. Greif Philipp A, Konstandin Nikola P, Metzeler Klaus H, Herold Tobias, Pasalic Zlatana, Ksienzyk Bianka, Dufour Annika, Schneider Friederike, Schneider Stephanie, Kakadia Purvi M, Braess Jan, Sauerland Maria Cristina, Berdel Wolfgang E, Büchner Thomas, Woermann Bernhard J, Hiddemann Wolfgang, Spiekermann Karsten, Bohlander Stefan |
|
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Sep 30 (27): 3376-82. Bejar Rafael, Stevenson Kristen E, Caughey Bennett A, Abdel-Wahab Omar, Steensma David P, Galili Naomi, Raza Azra, Kantarjian Hagop, Levine Ross L, Neuberg Donna, Garcia-Manero Guillermo, Ebert Benjamin |
|
ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
Genes, chromosomes & cancer 2012 Apr 51 (4): 328-37. Haferlach Claudia, Bacher Ulrike, Schnittger Susanne, Alpermann Tamara, Zenger Melanie, Kern Wolfgang, Haferlach Torst |
|
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.
Blood 2012 Apr 119 (15): 3578-84. Thol Felicitas, Kade Sofia, Schlarmann Carola, Löffeld Patrick, Morgan Michael, Krauter Jürgen, Wlodarski Marcin W, Kölking Britta, Wichmann Martin, Görlich Kerstin, Göhring Gudrun, Bug Gesine, Ottmann Oliver, Niemeyer Charlotte M, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
|
AML1/RUNX1 gene point mutations in childhood myeloid malignancies.
Pediatric blood & cancer 2011 Oct 57 (4): 583-7. Migas Alexandr, Savva Natallia, Mishkova Olga, Aleinikova Olga |
|
Clinical effect of point mutations in myelodysplastic syndromes.
The New England journal of medicine 2011 Jun 364 (26): 2496-506. Bejar Rafael, Stevenson Kristen, Abdel-Wahab Omar, Galili Naomi, Nilsson Björn, Garcia-Manero Guillermo, Kantarjian Hagop, Raza Azra, Levine Ross L, Neuberg Donna, Ebert Benjamin |
|
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
British journal of haematology 2010 Nov 151 (4): 365-75. Gelsi-Boyer Véronique, Trouplin Virginie, Roquain Julien, Adélaïde José, Carbuccia Nadine, Esterni Benjamin, Finetti Pascal, Murati Anne, Arnoulet Christine, Zerazhi Hacène, Fezoui Hacène, Tadrist Zoulika, Nezri Meyer, Chaffanet Max, Mozziconacci Marie-Joëlle, Vey Norbert, Birnbaum Dani |
|
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms.
Haematologica 2010 Sep 95 (9): 1473-80. Ernst Thomas, Chase Andrew, Zoi Katerina, Waghorn Katherine, Hidalgo-Curtis Claire, Score Joannah, Jones Amy, Grand Francis, Reiter Andreas, Hochhaus Andreas, Cross Nicholas C |
|
Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML.
Leukemia 2010 Aug 24 (8): 1528-32. Dicker F, Haferlach C, Sundermann J, Wendland N, Weiss T, Kern W, Haferlach T, Schnittger |
|
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias.
BMC cancer 2010 10 (1): 401. Rocquain Julien, Carbuccia Nadine, Trouplin Virginie, Raynaud Stéphane, Murati Anne, Nezri Meyer, Tadrist Zoulika, Olschwang Sylviane, Vey Norbert, Birnbaum Daniel, Gelsi-Boyer Véronique, Mozziconacci Marie-Joel |
|
Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype.
Haematologica 2009 Feb 94 (2): 213-23. Akagi Tadayuki, Ogawa Seishi, Dugas Martin, Kawamata Norihiko, Yamamoto Go, Nannya Yasuhito, Sanada Masashi, Miller Carl W, Yung Amanda, Schnittger Susanne, Haferlach Torsten, Haferlach Claudia, Koeffler H Phill |
- Page last reviewed:Jul 30, 2019
- Page last updated:Feb 13, 2020
- Content source: